Skip to main content

Advertisement

SpringerLink
Log in

Incorporating margin status information in treatment decisions for women with ductal carcinoma in situ: a decision analysis

  • Clinical trial
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

To integrate margin status information into the decision to undergo radiation therapy (RT) following breast-conserving surgery (BCS) for women with ductal carcinoma in situ (DCIS). We developed a decision-analytic Markov model to project quality-adjusted life years (QALYs) for a hypothetical cohort of 55-year-old women with DCIS over a lifetime horizon treated with or without RT following BCS. We estimated the transition probabilities of local DCIS and invasive recurrences based on the margin status (free, close, or positive) from a systematic literature review. Other probability estimates and utilities were collected from the published literature. Using the conditions defined in this model, expected QALYs after BCS alone were better than those after BCS with RT under the free-margin scenario (15.72 vs. 15.58) and worse in the close-margin (15.44 vs. 15.50) and positive-margin scenarios (15.20 vs. 15.33). The probability of receiving a salvage mastectomy varied from 10 to 28%, depending on margin status and treatment. One-way sensitivity analyses showed that the optimal treatment was sensitive to patients’ preferences and RT side effects. Probabilistic sensitivity analyses revealed that BCS alone would be the best strategy in 54% of the cases under the free-margin scenario, 48% under the close-margin scenario, and 44% under the positive-margin scenario. This study illustrates that margin status is able to provide supplementary information on the decision of DCIS treatment. Our analyses also highlight the importance of patients’ preferences in decision making. Our findings suggest that RT is not necessary for all patients with DCIS undergoing BCS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Buchholz TA, Haffty BG, Harris JR (2007) Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? Yes. Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast. J Surg Oncol 95:610–613

    Article  PubMed  Google Scholar 

  2. Silverstein MJ, Lagios MD (2007) Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? No. One size does not fit all: an argument against the routine use of radiation therapy for all patients with ductal carcinoma in situ of the breast who elect breast conservation. J Surg Oncol 95:605–609

    Article  PubMed  Google Scholar 

  3. Baxter NN, Virnig BA, Durham SB et al (2004) Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 96:443–448

    Article  PubMed  Google Scholar 

  4. Rakovitch E, Pignol JP, Chartier C et al (2007) The management of ductal carcinoma in situ of the breast: a screened population-based analysis. Breast Cancer Res Treat 101:335–347

    Article  PubMed  Google Scholar 

  5. Fisher B, Costantino J, Redmond C et al (1993) Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328:1581–1586

    Article  CAS  PubMed  Google Scholar 

  6. EORTC Breast Cancer Cooperative Group, EORTC Radiotherapy Group, Bijker N et al (2006) Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853—A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24:3381–3387

    Article  PubMed  Google Scholar 

  7. Holmberg L, Garmo H, Granstrand B et al (2008) Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol 26:1247–1252

    Article  PubMed  Google Scholar 

  8. Silverstein MJ (2008) Ductal carcinoma in situ of the breast: 11 reasons to consider treatment with excision alone. Womens Health (London, England) 4:565–577

    Google Scholar 

  9. Wong JS, Kaelin CM, Troyan SL et al (2006) Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol 24:1031–1036

    Article  PubMed  Google Scholar 

  10. Lagios MD, Page DL, Silverstein MJ (2006) Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol 24:3809–3811

    Article  PubMed  Google Scholar 

  11. Hillner BE, Desch CE, Carlson RW et al (1996) Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma-in situ of the breast. J Clin Oncol 14:70–77

    CAS  PubMed  Google Scholar 

  12. Bordeleau L, Rakovitch E, Naimark DM et al (2001) A comparison of four treatment strategies for ductal carcinoma in situ using decision analysis. Cancer 92:23–29

    Article  CAS  PubMed  Google Scholar 

  13. Suh WW, Hillner BE, Pierce LJ et al (2005) Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys 61:1054–1061

    PubMed  Google Scholar 

  14. Silverstein MJ (2003) The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg 186:337–343

    Article  PubMed  Google Scholar 

  15. Boyages J, Delaney G, Taylor R (1999) Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer 85:616–628

    Article  CAS  PubMed  Google Scholar 

  16. Neuschatz AC, DiPetrillo T, Safaii H et al (2001) Margin width as a determinant of local control with and without radiation therapy for ductal carcinoma in situ (DCIS) of the breast. Int J Cancer 96(suppl):97–104

    Article  CAS  PubMed  Google Scholar 

  17. Silverstein MJ, Buchanan C (2003) Ductal carcinoma in situ: USC/Van Nuys prognostic index and the impact of margin status. Breast 12:457–471

    Article  PubMed  Google Scholar 

  18. Holland PA, Gandhi A, Knox WF et al (1998) The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ. Br J Cancer 77:110–114

    CAS  PubMed  Google Scholar 

  19. Dunne C, Burke JP, Morrow M et al (2009) Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 27:1615–1620

    Article  PubMed  Google Scholar 

  20. Lester SC, Connolly JL, Amin MB (2009) College of American pathologists protocol for the reporting of ductal carcinoma in situ. Arch Pathol Lab Med 133:13–14

    PubMed  Google Scholar 

  21. Virnig BA, Shamliyan TA, Tuttle TM et al (2009) Diagnosis and management of ductal carcinoma in situ. Evid Rep Technol Assess. No. 185. AHRQ Publication No.09-E018. Rockville, MD. Agency for Healthcare Research and Quality, September 2009. http://www.ahrq.gov/downloads/pub/evidence/pdf/dcis/dcis.pdf

  22. Cataliotti L, Distante V, Ciatto S et al (1992) Intraductal breast cancer: review of 183 consecutive cases. Eur J Cancer 28A:917–920

    Article  CAS  PubMed  Google Scholar 

  23. Chan KC, Knox WF, Sinha G et al (2001) Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ. Cancer 91:9–16

    Article  CAS  PubMed  Google Scholar 

  24. Cutuli B, Cohen-Solal-le Nir C, de Lafontan B et al (2002) Breast-conserving therapy for ductal carcinoma in situ of the breast: the French cancer centers’ experience. Int J Radiat Oncol Biol Phys 53:868–879

    PubMed  Google Scholar 

  25. Fish EB, Chapman JA, Miller NA et al (1998) Assessment of treatment for patients with primary ductal carcinoma in situ in the breast. Ann Surg Oncol 5:724–732

    Article  CAS  PubMed  Google Scholar 

  26. Fisher ER, Dignam J, Tan-Chiu E et al (1999) Pathologic findings from the national surgical adjuvant breast project (NSABP) eight-year update of protocol B-17: intraductal carcinoma. Cancer 86:429–438

    Article  CAS  PubMed  Google Scholar 

  27. Kestin LL, Goldstein NS, Martinez AA et al (2000) Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10-year results. Ann Surg 231:235–245

    Article  CAS  PubMed  Google Scholar 

  28. MacAusland SG, Hepel JT, Chong FK et al (2007) An attempt to independently verify the utility of the Van Nuys prognostic index for ductal carcinoma in situ. Cancer 110:2648–2653

    Article  PubMed  Google Scholar 

  29. MacDonald HR, Silverstein MJ, Mabry H et al (2005) Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins. Am J Surg 190:521–525

    Article  PubMed  Google Scholar 

  30. Ringberg A, Idvall I, Ferno M et al (2000) Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast. Eur J Surg Oncol 26:444–451

    Article  CAS  PubMed  Google Scholar 

  31. Tunon-de-Lara C, de Mascarel I, Mac-Grogan G et al (2001) Analysis of 676 cases of ductal carcinoma in situ of the breast from 1971 to 1995: diagnosis and treatment—the experience of one institute. Am J Clin Oncol 24:531–536

    Article  CAS  PubMed  Google Scholar 

  32. Warneke J, Grossklaus D, Davis J et al (1995) Influence of local treatment on the recurrence rate of ductal carcinoma in situ. J Am Coll Surg 180:683–688

    CAS  PubMed  Google Scholar 

  33. Ben-David MA, Sturtz DE, Griffith KA et al (2007) Long-term results of conservative surgery and radiotherapy for ductal carcinoma in situ using lung density correction: the University of Michigan experience. Breast J 13:392–400

    Article  PubMed  Google Scholar 

  34. Fisher B, Land S, Mamounas E et al (2001) Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin Oncol 28:400–418

    Article  CAS  PubMed  Google Scholar 

  35. Nakamura S, Woo C, Silberman H et al (2002) Breast-conserving therapy for ductal carcinoma in situ: a 20-year experience with excision plus radiation therapy. Am J Surg 184:403–409

    Article  PubMed  Google Scholar 

  36. Rodrigues N, Carter D, Dillon D et al (2002) Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy. Int J Radiat Oncol Biol Phys 54:1331–1335

    PubMed  Google Scholar 

  37. Sahoo S, Recant WM, Jaskowiak N et al (2005) Defining negative margins in DCIS patients treated with breast conservation therapy: the University of Chicago experience. Breast J 11:242–247

    Article  PubMed  Google Scholar 

  38. Solin LJ, Fourquet A, Vicini FA et al (2005) Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 103:1137–1146

    Article  PubMed  Google Scholar 

  39. Turaka A, Freedman GM, Li T et al (2009) Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation. J Surg Oncol 100:25–31

    Article  PubMed  Google Scholar 

  40. Vicini FA, Kestin LL, Goldstein NS et al (2001) Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in situ treated with breast-conserving therapy. J Surg Oncol 76:245–254

    Article  CAS  PubMed  Google Scholar 

  41. Vicini FA, Recht A (2002) Age at diagnosis and outcome for women with ductal carcinoma-in situ of the breast: a critical review of the literature. J Clin Oncol 20:2736–2744

    Article  PubMed  Google Scholar 

  42. Vicini FA, Kestin LL, Goldstein NS et al (2000) Impact of young age on outcome in patients with ductal carcinoma-in situ treated with breast-conserving therapy. J Clin Oncol 18:296–306

    CAS  PubMed  Google Scholar 

  43. Vargas C, Kestin L, Go N et al (2005) Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Int J Radiat Oncol Biol Phys 63:1514–1521

    Article  PubMed  Google Scholar 

  44. Goldstein NS, Kestin L, Vicini FA (2000) Intraductal carcinoma of the breast: pathologic features associated with local recurrence in patients treated with breast-conserving therapy. Am J Surg Pathol 24:1058–1067

    Article  CAS  PubMed  Google Scholar 

  45. Smith BD, Haffty BG, Buchholz TA et al (2006) Effectiveness of radiation therapy in older women with ductal carcinoma in situ. J Natl Cancer Inst 98:1302–1310

    Article  PubMed  Google Scholar 

  46. Swain SM, Jeong JH, Geyer CE Jr et al (2010) Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med 362:2053–2065

    Article  CAS  PubMed  Google Scholar 

  47. Romero L, Klein L, Ye W et al (2004) Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast. Am J Surg 188:371–376

    Article  PubMed  Google Scholar 

  48. SEER cancer statistics review. National Cancer Institute (1975–2005). Accessed September 27, 2008, at http://seer.cancer.gov/csr/1975_2005/results_merged/sect_04_breast.pdf)

  49. National Vital Statistics Reports (2008). Accessed September 17, 2008, at http://www.cdc.gov/nchs/data/nvsr/nvsr57/nvsr57_01.pdf

  50. Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet 366:2087–2106

    CAS  PubMed  Google Scholar 

  51. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early breast cancer trialists’ collaborative group. Lancet 355:1757–1770, 2000

  52. Berrington de Gonzalez A, Curtis RE, Gilbert E et al (2010) Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer 102:220–226

    Article  CAS  PubMed  Google Scholar 

  53. Deutsch M, Land SR, Begovic M et al (2003) The incidence of lung carcinoma after surgery of breast carcinoma with and without postoperative radiotherapy. Result of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06. Cancer 98:1362–1368

    Article  PubMed  Google Scholar 

  54. Buchholz TA (2003) Lung carcinoma development after radiotherapy of breast carcinoma. Cancer 98:1331–1333

    Article  PubMed  Google Scholar 

  55. Buchholz TA (2009) Radiation therapy for early-stage breast cancer after breast-conserving surgery. N Engl J Med 360:63–70

    Article  CAS  PubMed  Google Scholar 

  56. Giordano SH, Kuo YF, Freeman JL et al (2005) Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97:419–424

    Article  PubMed  Google Scholar 

  57. Hayman JA, Kabeto MU, Schipper MJ et al (2005) Assessing the benefit of radiation therapy after breast-conserving surgery for ductal carcinoma-in situ. J Clin Oncol 23:5171–5177

    Article  PubMed  Google Scholar 

  58. Van den Hout WB, van der Linden YM, Steenland E et al (2003) Single-versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial. J Natl Cancer Inst 95:222–229

    Article  PubMed  Google Scholar 

  59. Briggs AH, Goeree R, Blackhouse G et al (2002) Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making 22:290–308

    PubMed  Google Scholar 

  60. Katz SJ, Lantz PM, Janz NK et al (2005) Patterns and correlations of local therapy for women with ductal carcinoma-in situ. J Clin Oncol 23:3001–3007

    Article  PubMed  Google Scholar 

  61. Hughes LL, Wang M, Page DL et al (2009) Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 27:5319–5324

    Article  PubMed  Google Scholar 

  62. Azu M, Abrahamse P, Katz SJ et al (2010) What is an adequate margin for breast-conserving surgery? Surgeon attitude and correlates. Ann Surg Oncol 17:558–563

    Article  PubMed  Google Scholar 

  63. Poland GP, Chan KC, Knox WF et al (2003) Value of the Van Nuys prognostic index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery. Br J Surg 90:426–432

    Article  Google Scholar 

  64. Gilleard O, Goodman A, Cooper M et al (2008) The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ. World J Surg Oncol 6:61

    Article  PubMed  Google Scholar 

  65. Di Saverio S, Catena F, Santini D et al (2008) 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up. Breast Cancer Res Treat 109:405–416

    Article  PubMed  Google Scholar 

  66. Kaufman EL, Jacobson JS, Hershman DL et al (2008) Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol 26:392–398

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Health Policy and Management, University of Minnesota School of Public Health, 420 Delaware Street S.E. MMC 729, Minneapolis, MN, 55455, USA

    Shi-Yi Wang, Karen Kuntz & Robert Kane

  2. Department of Surgery, University of Minnesota Medical School, Minneapolis, MN, USA

    Todd Tuttle

Authors
  1. Shi-Yi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karen Kuntz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Todd Tuttle
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert Kane
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shi-Yi Wang.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 118 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, SY., Kuntz, K., Tuttle, T. et al. Incorporating margin status information in treatment decisions for women with ductal carcinoma in situ: a decision analysis. Breast Cancer Res Treat 124, 393–402 (2010). https://doi.org/10.1007/s10549-010-1166-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-010-1166-7

Keywords

Search

Navigation